Skip to main content
Signal8

Byam Rebecca

SEC insider (Form 3/4/5 filer). CIK 0001866256. Chief Financial Officer at HCW Biologics Inc. (HCWB). 3 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in MIRAMAR, FL.

Companies Byam Rebecca has filed insider reports for

  • HCW Biologics Inc. (HCWB): Officer, Chief Financial Officer
Byam Rebecca profile photo

Byam Rebecca

CIK: 0001866256

Transaction Breakdown

Open Market Buys (P)3 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HCW Biologics Inc. logo
HCWB

HCW Biologics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 22, 2026
    Purchase
    Direct
    14.2K shares at avg. $1.41$20K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 8, 2025
    Purchase
    Direct
    8.5K shares at avg. $26.00$220K
  • HCW Biologics Inc. logo
    HCWB

    HCW Biologics Inc.

    May 7, 2025
    Purchase

    Common Stock Purchase Warrant

    Direct
    4.2K shares-

1-3 of 3